利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

25 条记录 (耗时 0.028 秒)

    In-Cab Communications Module
    5.
    发明申请
    In-Cab Communications Module 审中-公开
    驾驶室通信模块

    公开(公告)号：US20130002456A1

    公开(公告)日：2013-01-03

    申请号：US13598802

    申请日：2012-08-30

    申请人： Max L. Fuller ,  Kenneth W. Crane ,  Robert Lathrop ,  Scott Davison

    发明人： Max L. Fuller ,  Kenneth W. Crane ,  Robert Lathrop ,  Scott Davison

    IPC分类号： G08G1/13

    CPC分类号： G06Q10/0833 ,  G01C21/362 ,  G01C21/3629 ,  G01C21/3632 ,  G06F3/0488 ,  G06Q10/08 ,  G06Q30/04 ,  G08G1/202

    摘要： A communications module for conveying information to the driver of a truck is provided. The module is designed to reside in the cab of a truck that is carrying a full truckload of cargo. The communications module includes a user interface such as a screen. The communications module also has a modem. The modem is used for communicating with a host trucking management system through a wireless communications system. The communications module has a vehicle navigation system. The vehicle navigation system communicates with a GPS satellite system to generate maps on the user interface. The navigation system allows the driver to refer to a map on a screen for driving directions en route to a cargo pick-up location or other location. Further, the communications module includes a processing unit that is programmed to receive cargo delivery data sets from the host trucking management system.

    摘要翻译： 提供了一种用于将信息传送给卡车司机的通信模块。 该模块设计用于驻车的卡车的驾驶室，该货车正在运载一整批货物。 通信模块包括诸如屏幕的用户界面。 通信模块还具有调制解调器。 调制解调器用于通过无线通信系统与主机运输管理系统进行通信。 通信模块具有车辆导航系统。 车载导航系统与GPS卫星系统通信，在用户界面上生成地图。 导航系统允许驾驶员参考屏幕上的地图，以便在到达货物接收位置或其他位置的途中行驶路线。 此外，通信模块包括处理单元，其被编程为从主卡车管理系统接收货物传送数据集。

    Intravaginal treatment of vaginal infections with metronidazole compositions
    7.
    发明申请
    Intravaginal treatment of vaginal infections with metronidazole compositions 审中-公开
    用甲硝唑组合物对阴道感染进行阴道内治疗

    公开(公告)号：US20060093675A1

    公开(公告)日：2006-05-04

    申请号：US10978235

    申请日：2004-10-29

    申请人： Mathew Ebmeier ,  Robert Lathrop

    发明人： Mathew Ebmeier ,  Robert Lathrop

    IPC分类号： A61K9/14 ,  A61K31/4164

    CPC分类号： A61K9/0034 ,  A61K31/4164

    摘要： The present invention provides a buffered non-flowing composition suitable for the treatment of bacterial vaginosis. The composition includes metronidazole in a concentration of about 0.50% (w/w) to about 1.50% (w/w). The metronidazole is present together with a buffer system in a physiologically tolerable medium. The buffer system provides an acidic buffered pH value for the composition in the range of about 5.0 to about 6.0. The present invention also provides for a method for inhibiting a microorganism. The method includes contacting a microorganism with an effective amount of the composition of the present invention, for a period of time effective to inhibit the microorganism. The present invention also provides for a method for treating bacterial vaginosis in a human patient. The method includes intravaginal administration to a patient in need of such treatment an effective amount of the composition the present invention. The composition is introduced into the vagina at least once a day for a time period of at least one day.

    摘要翻译： 本发明提供了适用于治疗细菌性阴道病的缓冲非流动组合物。 组合物包含浓度为约0.50％（w / w）至约1.50％（w / w）的甲硝唑。 甲硝唑与缓冲系统一起存在于生理上可耐受的培养基中。 缓冲系统为组合物提供约5.0至约6.0范围内的酸性缓冲pH值。 本发明还提供了抑制微生物的方法。 该方法包括使微生物与有效量的本发明组合物接触一段有效抑制微生物的时间。 本发明还提供了一种在人类患者中治疗细菌性阴道病的方法。 该方法包括对需要这种治疗的患者的阴道内施用有效量的本发明的组合物。 每天至少一次将组合物引入阴道至少一天的时间。

    MEDICAMENT FOR THE TREATMENT OF VIRAL SKIN AND TUMOUR DISEASES
    9.
    发明申请
    MEDICAMENT FOR THE TREATMENT OF VIRAL SKIN AND TUMOUR DISEASES 有权
    用于治疗病毒性皮肤病和肿瘤病的药物

    公开(公告)号：US20110009481A1

    公开(公告)日：2011-01-13

    申请号：US12887250

    申请日：2010-09-21

    申请人： Yunik Chang ,  Robert Lathrop ,  Erwin Böhm ,  Irene Gander-Meisterernst ,  Regina Greger ,  Johanna Holldack ,  Ulrich Moebius

    发明人： Yunik Chang ,  Robert Lathrop ,  Erwin Böhm ,  Irene Gander-Meisterernst ,  Regina Greger ,  Johanna Holldack ,  Ulrich Moebius

    IPC分类号： A61K31/353 ,  A61P35/00 ,  A61P17/00

    CPC分类号： A61K9/0014 ,  A61K31/23 ,  A61K31/353 ,  A61K47/06 ,  A61K47/10 ,  A61K47/14 ,  Y10S514/934 ,  Y10S514/947 ,  Y10S514/967 ,  Y10S514/969 ,  A61K2300/00

    摘要： The invention relates to a medicament containing a compound of general formula (I), where R1=independently, a straight or branched, saturated, singly- or multiply-unsaturated, optionally substituted C11-C21 alkyl, alkylene or alkinyl group, preferably a C11-C15 alkyl, alkylene or alkinyl group, particularly a C11-C13 alkyl, alkylene or alkinyl group, most preferably a C13 alkyl group, R2=independently, a straight or branched C1-C8 alkyl, alkylene or alkinyl group, preferably a C1-C6 alkyl, alkylene or alkinyl group, in particular a C2-C4 alkyl, alkylene or alkinyl group, most preferably a C3 alkyl group, a —[CH2—(CH2)m-O]nH group with n=1 to 10, preferably n=1 to 5, to m=1 to 5, preferably m=1 to 3, a —CH2—[CH—(OH)]p[CH2—R3]- group, where R3=independently H or OH, p=1 to 7, preferably p=1 to 4, a pentose group or a hexose group, as therapeutically active agent, alone or in combination with one or several further pharmaceutical agents as a combination preparation for the treatment of viral skin diseases and/or tumor diseases, in particular caused by human papilloma virus (HPV) and/or herpes viruses and a topically acting medicament formulation and the use thereof.

    摘要翻译： 本发明涉及含有通式（I）化合物的药物，其中R 1独立地为直链或支链的，饱和的，单或多不饱和的任选取代的C 11 -C 21烷基，亚烷基或炔基，优选C 11 -C 15烷基，亚烷基或炔基，特别是C 11 -C 13烷基，亚烷基或炔基，最优选C 13烷基，R 2独立地为直链或支链C 1 -C 8烷基，亚烷基或炔基，优选C1- C 1 -C 6烷基，亚烷基或炔基，特别是C 2 -C 4烷基，亚烷基或炔基，最优选C 3烷基， - n = 1-10的α-[CH 2 - （CH 2）m O] n H基，优选n = 1至5，m = 1至5，优选m = 1至3，-CH 2 - [CH-（OH）] p [CH 2 -R 3] - 基，其中R 3独立地为H或OH，p = 7，优选p = 1〜4，戊糖基或己糖基作为治疗活性剂，单独或与一种或几种其它药剂组合，作为tre的组合制剂 特别是由人乳头瘤病毒（HPV）和/或疱疹病毒和局部作用的药物制剂引起的病毒性皮肤病和/或肿瘤疾病的发生及其用途。